# Cardiomyopathy, Hypertrophic studies recruiting: 54 (2026)

Updated November 19, 2026.

ClinicalTrials.gov lists 54 trials that are observational for Cardiomyopathy, Hypertrophic that are recruiting or not yet recruiting, as read on November 19, 2026.

## The full list

Recruiting observational Cardiomyopathy, Hypertrophic studies: 54 rows for $5, recruiting or not yet recruiting on ClinicalTrials.gov as read on November 19, 2026. Columns: NCT ID, Title, Sponsor, Sponsor class, Phase, Status, Conditions, Condition groups (MeSH), Interventions, Start date, First posted, Last update posted, Enrollment, Location countries, Read on, Source. The new rows each week by email, about 1 row a month: $19 a month. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (sponsor class, condition groups (MeSH), interventions, start date, last update posted and location countries), which open on your screen as soon as the payment clears and come by email. The rows on this page are a sample.

Buy: https://specstream.ai/data/clinical-trials/recruiting/observational/cardiomyopathy-hypertrophic

SpecStream is the live web data engine for teams and agents. It reads ClinicalTrials.gov each morning, and this page is that reading. Ask for the sponsors, conditions, phases or places you follow and each new or changed trial arrives in your sheet, CRM, Slack or agent with the sponsor, phase, status and sites.

- Trials: 54
- Recruiting or not yet: 54
- Read on: November 19, 2026

## Trials

The 25 newest of 54, each linked to its ClinicalTrials.gov record. The full list holds every one.

| First posted | NCT ID | Title | Sponsor | Phase | Status | Conditions | Enrollment | Source |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| September 29, 2026 | NCT07846176 | Aficamten and Patient-Reported Outcomes in Real-World nHCM | Second Affiliated Hospital, Zhejiang University, School of Medicine | Observational | Not yet recruiting | Hypertrophic Cardiomyopathy (HCM) | 100 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07846176) |
| September 29, 2026 | NCT07846059 | Evaluation of Mavacamten-Based Practice in Chinese Adults With Obstructive Hypertrophic Cardiomyopathy | Bristol-Myers Squibb | Observational | Not yet recruiting | Obstructive Hypertrophic Cardiomyopathy (oHCM) | 800 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07846059) |
| September 21, 2026 | NCT07831811 | Echocardiographic Perspectives on Transient Mitral Regurgitation After Septal Myectomy | University Health Network, Toronto | Observational | Not yet recruiting | Hypertrophic Cardiomyopathy | 150 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07831811) |
| July 21, 2026 | NCT07716826 | IMPACT-CMH: Impact of Mitral Valve and Subvalvular Abnormalities in Obstructive Hypertrophic Cardiomyopathy Treated With Mavacamten | French Cardiology Society | Observational | Not yet recruiting | Cardiomyopathy, Hypertrophic Obstructive | 150 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07716826) |
| June 10, 2026 | NCT07638033 | A Real-world HCM-cohort Trial | Xijing Hospital | Observational | Not yet recruiting | Hypertrophic Cardiomyopathy (HCM) | 3,000 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07638033) |
| April 29, 2026 | NCT07557498 | Mavacamten Outcomes in Hypertrophic Cardiomyopathy (HCM) and the Associated Patient and Physician Experiences in the US | Bristol-Myers Squibb | Observational | Recruiting | Obstructive Hypertrophic Cardiomyopathy (oHCM) | 362 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07557498) |
| April 21, 2026 | NCT07541833 | Effectiveness and Treatment Patterns of Mavacamten in Patients With Obstructive Hypertrophic Cardiomyopathy in Japan (MANAGE-HCM) | Bristol-Myers Squibb | Observational | Recruiting | Cardiomyopathy | 36 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07541833) |
| March 6, 2026 | NCT07454135 | Mechanisms of Atrial Pathoelectrophysiology in HCM | Guy's and St Thomas' NHS Foundation Trust | Observational | Recruiting | Hypertrophic Cardiomyopathy (HCM), Atrial Fibrillation (AF) | 40 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07454135) |
| February 27, 2026 | NCT07439952 | Biological Collection for the Purpose of Exploring Genetic and Clinical-biological Factors Associated With Variability in Response to... | Assistance Publique - Hôpitaux de Paris | Observational | Not yet recruiting | Obstructive Hypertrophic Cardiomyopathy (oHCM) | 300 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07439952) |
| February 23, 2026 | NCT07428031 | French Registry: Late Gadolinium Enhancement in Hypertrophic Cardiomyopathy | Assistance Publique - Hôpitaux de Paris | Observational | Not yet recruiting | Cardiomyopathy, Hypertrophic Cardiomyopathies | 5,000 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07428031) |
| February 19, 2026 | NCT07420907 | Study of the Progression of Chronic Cardiovascular Conditions | Prolaio | Observational | Recruiting | Cardiovascular Disease (CVD), Heart Failure, Aortic Stenosis, Aortic Stenosis Disease, Hypertension, Hypertension... | 5,000 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07420907) |
| February 13, 2026 | NCT07408427 | Precision Pharmacogenetics and Genotype Class Based Prediction of Mavacamten Response in Obstructive Hypertrophic Cardiomyopathy | University of Manchester | Observational | Not yet recruiting | Hypertrophic Cardiomyopathy (HCM) | 140 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07408427) |
| February 3, 2026 | NCT07383025 | Mavacamten Post-marketing Surveillance in Patients With Obstructive Hypertrophic Cardiomyopathy in Japan | Bristol-Myers Squibb | Observational | Recruiting | Obstructive Hypertrophic Cardiomyopathy (oHCM) | 200 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07383025) |
| February 2, 2026 | NCT07382128 | Myocardial Perfusion CMR for Differentiating and Characterizing Hypertrophic Cardiomyopathy Phenotypes | IRCCS Azienda Ospedaliero-Universitaria di Bologna | Observational | Recruiting | HCM - Hypertrophic Cardiomyopathy, Anderson Fabry Disease, Cardiac Magnetic Resonance Imaging, Amyloid Cardiomyopathy | 250 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07382128) |
| February 2, 2026 | NCT07381894 | Multicentre Hypertrophic Cardiomyopathy Registry | University of Manchester | Observational | Recruiting | Hypertrophic Cardiomyopathy (HCM) | 2,500 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07381894) |
| January 23, 2026 | NCT07361289 | A Study to Assess the Real-World Effectiveness of Mavacamten in Adult Patients With Obstructive Hypertrophic Cardiomyopathy in China | Bristol-Myers Squibb | Observational | Recruiting | Hypertrophic Cardiomyopathy | 500 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07361289) |
| January 22, 2026 | NCT07359690 | Multimodal Analysis of Endomyocardial Biopsies | University Hospital, Essen | Observational | Recruiting | Heart Transplantation, Dilated Cardiomyopathy (DCM), Hypertrophic Cardiomyopathy (HCM), Myocarditis, Pericarditis... | 216 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07359690) |
| January 21, 2026 | NCT07354646 | The Application of T1 Mapping in Real-World | Chinese Academy of Medical Sciences, Fuwai Hospital | Observational | Recruiting | Myocardial Infarction (MI), Hypertrophic Cardiomyopathy (HCM), Dilated Cardiomyopathy (DCM), Arrhythmogenic... | 2,000 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07354646) |
| January 15, 2026 | NCT07344480 | Retrospective Natural History Study of RASopathy-associated Cardiomyopathy (RAS-CM) | Sponsor not shown (see the record) | Observational | Recruiting | Hypertrophic Cardiomyopathy (HCM), Heart Failure, RASopathy | 100 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07344480) |
| January 12, 2026 | NCT07332767 | Myocardial Energetic Restoration in the Treatment of Obstructive Hypertrophic Cardiomyopathy | University of Manchester | Observational | Not yet recruiting | Hypertrophic Cardiomyopathy (HCM) | 20 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07332767) |
| December 4, 2025 | NCT07263204 | AI-Enabled Diagnosis and Prognosis of Hypertrophic Cardiomyopathy | Second Affiliated Hospital, Zhejiang University, School of Medicine | Observational | Recruiting | Hypertrophic Cardiomyopathy (HCM), Left Ventricular Hypertrophy | 15,000 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07263204) |
| September 2, 2025 | NCT07150299 | Myocardial Perfusion Changes Following Optimal Medical Treatment in Symptomatic Hypertrophic Cardiomyopathy | Medical University of Vienna | Observational | Recruiting | Hypertrophic Obstructive Cardiomyopathy \\(HOCM\\) | 20 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07150299) |
| July 8, 2025 | NCT07054073 | HCMR Re-Imaging Study | Sponsor not shown (see the record) | Observational | Recruiting | Hypertrophic Cardiomyopathy (HCM) | 314 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07054073) |
| February 7, 2025 | NCT06813443 | Characterization of Patients With Cardiomyopathy to Identify Critical Patients Candidates for Cardiac Transplantation | IRCCS Azienda Ospedaliero-Universitaria di Bologna | Observational | Recruiting | Cardiomyopathies, Amyloidosis Cardiac, Fabry Disease, Arrhythmogenic Cardiomyopathy, Hypertrophic Cardiomyopathy (HCM)... | 700 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06813443) |
| January 15, 2025 | NCT06775665 | A Real-World Study on Hypertrophic Cardiomyopathy in Chinese Population | Second Affiliated Hospital, Zhejiang University, School of Medicine | Observational | Recruiting | Hypertrophic Cardiomyopathy (HCM) | 3,000 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06775665) |

## Sponsors with the most

| Sponsor | Trials |
| --- | --- |
| [Bristol-Myers Squibb](https://specstream.ai/data/clinical-trials/company/bristol-myers-squibb) | 9 |
| Second Affiliated Hospital, Zhejiang University, School of Medicine | 3 |
| Assistance Publique - Hôpitaux de Paris | 3 |
| University of Manchester | 3 |
| China National Center for Cardiovascular Diseases | 2 |
| French Cardiology Society | 2 |
| IRCCS Azienda Ospedaliero-Universitaria di Bologna | 2 |
| Imperial College London | 2 |
| Hospital do Coracao | 1 |
| Xijing Hospital | 1 |
| Centro Medico Teknon | 1 |
| Magdi Yacoub Heart Foundation | 1 |
| Far Eastern Memorial Hospital | 1 |
| Hospital Italiano de Buenos Aires | 1 |
| Fatebenefratelli Hospital | 1 |
| National Heart Centre Singapore | 1 |
| University Hospital Heidelberg | 1 |
| Guy's and St Thomas' NHS Foundation Trust | 1 |
| Shanghai Zhongshan Hospital | 1 |
| Scientific Institute San Raffaele | 1 |
| Medical University of Vienna | 1 |
| Montefiore Medical Center | 1 |
| McGill University Health Centre/Research Institute of the McGill University Health Centre | 1 |
| Prolaio | 1 |
| University Hospital, Essen | 1 |

## By country

| Country | Trials |
| --- | --- |
| United States | 9 |
| United Kingdom | 9 |
| China | 8 |
| Italy | 5 |
| Germany | 5 |
| France | 4 |
| Austria | 3 |
| Spain | 2 |
| Japan | 2 |
| Canada | 2 |
| Brazil | 1 |
| Portugal | 1 |
| Egypt | 1 |
| Taiwan | 1 |
| Argentina | 1 |
| South Korea | 1 |
| Singapore | 1 |
| Czechia | 1 |
| Poland | 1 |
| Puerto Rico | 1 |

## Where the register publishes

- [ClinicalTrials.gov](https://clinicaltrials.gov/)
- [ClinicalTrials.gov API](https://clinicaltrials.gov/data-api/api)

Source: [ClinicalTrials.gov API v2 (U.S. National Library of Medicine)](https://clinicaltrials.gov/data-api/api). U.S. government data; ClinicalTrials.gov terms of use. Studies are as their sponsors registered them on ClinicalTrials.gov, read through its API. Recruiting means the record's overall status is recruiting or not yet recruiting. Condition groups are the MeSH terms ClinicalTrials.gov assigns; a condition page also counts the narrower terms that name it, as the register's own search does (triple negative breast neoplasms are breast neoplasms). Sites are shown as organizations only; no investigator or contact is read or shown.

Free to quote with credit and a link. Copying in bulk needs a [data licence](https://specstream.ai/data/licence).

## Business lists in the United States

- [Persian restaurants in the United States](https://specstream.ai/data/businesses/persian-restaurants/united-states)
- [T-shirt printers in the United States](https://specstream.ai/data/businesses/t-shirt-printers/united-states)
- [Automation companies in the United States](https://specstream.ai/data/businesses/automation-companies/united-states)
- [Computer training centers in the United States](https://specstream.ai/data/businesses/computer-training-centers/united-states)
- [Gardening services in the United States](https://specstream.ai/data/businesses/gardening-services/united-states)
- [Mattress manufacturing companies in the United States](https://specstream.ai/data/businesses/mattress-manufacturing-companies/united-states)
